Roche is set to introduce its three next-generation SARS-CoV-2 rapid antigen tests (‘2.0’) for self-test and professional use in countries that accept the CE...
Adaptive Biotechnologies has collaborated with Epic for the integration of the clonoSEQAssay into the latter’s comprehensive electronic medical record (EMR) system.
The clonoSEQ Assay is...
SetPoint Medical has enrolled the first participant in the second stage of the RESET-RA pivotal study, which is assessing the company’s investigational platform technology...
